David Berger
Net worth: 232 998 $ as of 2024-03-30
Profile
David B. Berger holds the position of Chief Business Operations & Compliance Officer at Tandem Diabetes Care, Inc. In his past career he occupied the position of Attorney at Amylin Pharmaceuticals, Inc., Attorney at Cooley Godward LLP, Secretary, Senior Vice President & General Counsel for Senomyx, Inc., Vice President-Legal Affairs at Alere San Diego, Inc. and Vice President-Legal Affairs at Biosite, Inc. (Massachusetts). Mr. Berger received an undergraduate degree from the University of California, Berkeley and a graduate degree from Stanford Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-11-26 | 6,580 ( 0.01% ) | 232 998 $ | 2024-03-30 |
Former positions of David Berger
| Companies | Position | End |
|---|---|---|
| TANDEM DIABETES CARE, INC. | Compliance Officer | 2022-02-02 |
| SENOMYX INC. | General Counsel | 2013-08-01 |
| Biosite, Inc. (Massachusetts) | General Counsel | 2007-09-30 |
Alere San Diego, Inc.
 Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | General Counsel | 2006-12-31 |
Cooley Godward LLP
 Cooley Godward LLP Miscellaneous Commercial ServicesCommercial Services Cooley Goodword LLP is the law firm specializes in providing services to both new and established information technology and life sciences companies. Cooley also provides counsel in areas of business law that include trade regulation, employment and labor, investment banking issues, securities litigation, IPOs, mergers and acquisitions, patent enforcement and venture capital funding. It is located in Palo Alto, CA. | Corporate Officer/Principal | 2002-12-31 |
Training of David Berger
| University of California, Berkeley | Undergraduate Degree |
| Stanford Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TANDEM DIABETES CARE, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Health Technology |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Cooley Godward LLP
Cooley Godward LLP Miscellaneous Commercial ServicesCommercial Services Cooley Goodword LLP is the law firm specializes in providing services to both new and established information technology and life sciences companies. Cooley also provides counsel in areas of business law that include trade regulation, employment and labor, investment banking issues, securities litigation, IPOs, mergers and acquisitions, patent enforcement and venture capital funding. It is located in Palo Alto, CA. | Commercial Services |
| Biosite, Inc. (Massachusetts) |
- Stock Market
- Insiders
- David Berger
